An increase of the native interstitial adenosine concentration during histidine application.
We examined whether histidine can increase the production of interstitial adenosine via noradrenaline (NA) release-mediated activation of ecto-5'-nucleotidase in the ventricular myocardium, with use of microdialysis techniques in in situ rat hearts. The microdialysis probe was implanted in the left ventricular myocardium of anesthetized rat hearts and the tissue was perfused with Tyrode's solution containing adenosine 5'-monophosphate (AMP) through the dialysis probe at a rate of 1.0 microl/min. Adenosine in the dialysate collected during perfusion with Tyrode's solution containing 100 microM AMP (through the probe) originated from the hydrolysis of AMP catalyzed by endogenous ecto-5'-nucleotidase, so that the level of adenosine reflected the activity of ecto-5'-nucleotidase in this tissue. In the presence of NA (10 microM), histidine, a scavenger of highly active singlet oxygen (1O2), significantly increased concentration of adenosine. Histidine (5-50 mM) increased the level of AMP-primed dialysate adenosine in a concentration-dependent manner. When histidine (25 mM) was infused to rat myocardium, small increase in the levels of adenosine were observed. However, when corresponding experiments were performed with NA (10 microM)-pretreated animals, a marked elevation of the level of adenosine in rat heart dialysate was obtained. To confirm the possible mechanism of interaction between 1O2 and NA, we examined the effect of histidine in ischemic-reperfused rat hearts. In the presence of histidine (25 mM), a marked elevation of NA and adenosine was observed. However, when corresponding experiments were performed with reserpinized rat hearts, the elevation of both NA and adenosine was not observed in ischemia-reperfused rat hearts. These results indicate that histidine increases interstitial adenosine concentration via NA release-mediated activation of ecto-5'-nucleotidase.
Obata
T
T
Department of Pharmacology, Oita Medical University, Japan. tobata@oita-med.ac.jp
Yamanaka
Y
Y
D015720:5'-Nucleotidase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000241:Adenosine / Q000378:metabolism*; D000249:Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D015314:Dialysis Solutions / Q000032:analysis; D006639:Histidine / Q000494:pharmacology*; D008297:Male; D017551:Microdialysis; D017202:Myocardial Ischemia / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D017382:Reactive Oxygen Species / Q000378:metabolism; D015427:Reperfusion Injury / Q000378:metabolism
D015314:Dialysis Solutions; D017382:Reactive Oxygen Species; D000249:Adenosine Monophosphate; D006639:Histidine; D015720:5'-Nucleotidase; D000241:Adenosine; D009638:Norepinephrine